关于绝经后女性预防性激素治疗的咨询指南。美国医师学会。 - Suppr

Suppr

超能文献

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians.

出版信息

Ann Intern Med. 1992 Dec 15;117(12):1038-41. doi: 10.7326/0003-4819-117-12-1038.

DOI:10.7326/0003-4819-117-12-1038

PMID:1443972

Abstract

摘要

相似文献

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians.关于绝经后女性预防性激素治疗的咨询指南。美国医师学会。

Ann Intern Med. 1992 Dec 15;117(12):1038-41. doi: 10.7326/0003-4819-117-12-1038.

Guidelines for postmenopausal preventive hormone therapy: a policy review. American College of Physicians.绝经后预防性激素治疗指南：一项政策审查。美国医师学会。

J Am Board Fam Pract. 1993 Mar-Apr;6(2):153-62.

Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.绝经后激素替代疗法与子宫内膜癌的病例对照研究

Am J Epidemiol. 2006 Oct 15;164(8):775-86. doi: 10.1093/aje/kwj316. Epub 2006 Sep 22.

[Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].[绝经后激素治疗——最新进展。益处与风险——识别乳腺癌风险增加的女性很重要]

Lakartidningen. 2009;106(34):2041-2.

Postmenopausal hormone therapy and breast cancer.绝经后激素治疗与乳腺癌

Prescrire Int. 2009 Apr;18(100):66-7.

Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.绝经后激素治疗女性中凝血酶生成增加：雌激素给药途径和孕激素的重要性。

Menopause. 2011 Aug;18(8):873-9. doi: 10.1097/gme.0b013e31820eee88.

Postmenopausal hormone therapy.绝经后激素治疗

Ann Intern Med. 1993 Aug 15;119(4):347; author reply 347-8. doi: 10.7326/0003-4819-119-4-199308150-00029.

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].[激素疗法与绝经后女性静脉血栓栓塞风险]

Rev Prat. 2005 Feb 28;55(4):389-92.

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.绝经后女性的激素治疗与子宫内膜增生风险：Cochrane系统评价总结

Maturitas. 2014 Jan;77(1):4-6. doi: 10.1016/j.maturitas.2013.10.002. Epub 2013 Oct 11.

Is combined estrogen/progestogen hormone therapy worth the risk?雌激素/孕激素联合激素疗法值得冒风险吗？

Climacteric. 2003 Sep;6(3):177-9.

引用本文的文献

Patient perspective: Is intensive screening of women at high risk of breast cancer evidence-based medicine or ?患者视角：对乳腺癌高危女性进行强化筛查是循证医学还是？（原文最后“or”后面似乎内容不完整）

Womens Health (Lond). 2025 Jan-Dec;21:17455057241307089. doi: 10.1177/17455057241307089.

Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.雌三醇/G 蛋白偶联受体/丝氨酸蛋白酶抑制剂 B2 转导信号抑制三阴性乳腺癌细胞的迁移。

J Transl Med. 2024 May 13;22(1):450. doi: 10.1186/s12967-024-05269-6.

Serum ischemia-modified albumin level returns to its premenopausal level with 1-year hormone therapy in healthy menopausal women.在健康绝经后女性中，血清缺血修饰白蛋白水平在接受1年激素治疗后恢复到绝经前水平。

Prz Menopauzalny. 2021 Jun;20(2):76-80. doi: 10.5114/pm.2021.106089. Epub 2021 May 23.

Does publication bias explain the divergent findings on menopausal hormone therapy and cardioprotection in the literature?发表偏倚能否解释文献中关于更年期激素治疗与心脏保护作用的不同研究结果？

Res Pract Thromb Haemost. 2021 May 4;5(4):e12515. doi: 10.1002/rth2.12515. eCollection 2021 May.

Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.绝经激素治疗与乳腺密度和乳腺癌风险的关系：E3N 队列研究的结果。

Breast Cancer Res. 2021 Apr 17;23(1):47. doi: 10.1186/s13058-021-01425-8.

Menopausal Hormone Therapy and Health Outcomes: Is Timing Everything?绝经激素治疗与健康结局：时机决定一切？

Clin Chem. 2021 Jan 8;67(1):317-318. doi: 10.1093/clinchem/hvaa286.

The Controversial History of Hormone Replacement Therapy.激素替代疗法的争议历史。

Medicina (Kaunas). 2019 Sep 18;55(9):602. doi: 10.3390/medicina55090602.

Evaluation of Estrogenic Activity of Extract from the Herbal Mixture Hemsley Turczaninow, and Nakai.中药混合物赫姆斯利氏旋覆花（Hemsley Turczaninow）和中井氏旋覆花（Nakai）提取物雌激素活性的评估

Toxicol Res. 2017 Jan;33(1):71-77. doi: 10.5487/TR.2017.33.1.071. Epub 2017 Jan 15.

Estrogen deficiency heterogeneously affects tissue specific stem cells in mice.雌激素缺乏对小鼠组织特异性干细胞产生异质性影响。

Sci Rep. 2015 Aug 6;5:12861. doi: 10.1038/srep12861.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.绝经激素治疗与妇女健康倡议随机试验干预和停药后扩展阶段的健康结局。

JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验